Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × Panitumumab × Clear all

NCT05564377 2026-03-18

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Phase 2 Recruiting

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

NCT01296035 2015-08-25

PanGem

Phase 2 Terminated

8 enrolled 6 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms